×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
All You Need to Know About Oncternal Therapeutics (ONCT) Rating Upgrade to Buy
Yahoo Finance Canada
Oncternal Therapeutics (ONCT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a...
9 hours ago
Oncternal Therapeutics to Provide Business Update and Report First Quarter 2024 Financial Results
GlobeNewswire
SAN DIEGO, May 02, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused...
6 days ago
Oncternal Therapeutics reports patient death in CAR-T dose-escalation study
Fierce Biotech
Oncternal Therapeutics has reported the death of a patient in a clinical trial following an elevated dose of its autologous CAR-T therapy...
4 months ago
Oncternal Therapeutics (NASDAQ:ONCT) Coverage Initiated at StockNews.com
Defense World
Read Oncternal Therapeutics (NASDAQ:ONCT) Coverage Initiated at StockNews.com at Defense World.
5 days ago
Can Oncternal Therapeutics (NASDAQ:ONCT) Afford To Invest In Growth?
Simply Wall St
You can calculate a company's cash runway by dividing the amount of cash it has by the rate at which it is spending that cash. In September 2023...
2 months ago
Oncternal Therapeutics reports inducement award under Nasdaq listing rule - TipRanks.com
Tipranks
Oncternal Therapeutics announced the approval of an inducement award to one new employee, Anne C. Hansen, who is joining Oncternal as Senior...
1 week ago
Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results
Yahoo Finance
SAN DIEGO, March 07, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on...
2 months ago
Oncternal Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line
Yahoo Finance
Oncternal Therapeutics ( NASDAQ:ONCT ) Full Year 2023 Results Key Financial Results Net loss: US$39.5m (loss narrowed...
1 month ago
Oncternal Therapeutics Announces Reverse Stock Split
Yahoo Finance
SAN DIEGO, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused...
4 months ago
Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q4 2023 Earnings Call Transcript
Yahoo Finance
Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q4 2023 Earnings Call Transcript March 7, 2024 Oncternal Therapeutics, Inc. isn't one of the 30...
2 months ago